Clinical safety and performance of the world’s thinnest-strut Evermine50 everolimus-eluting stent: a 24-month follow-up of the Evermine 50 EES – 1 study
AsiaIntervention 2024;10:195-202
Impact of acute coronary syndrome on early in-stent neoatherosclerosis as shown by optical coherence tomography
AsiaIntervention 2024;10:203-211
Hybrid strategy of drug-eluting stent and drug-coated balloon in the treatment of de novo coronary artery disease: 1-year clinical outcomes
AsiaIntervention 2024;10:212-218
A hospital lipid-lowering protocol improves 2-year clinical outcomes in patients with acute coronary syndrome
AsiaIntervention 2024;10:169-176
Real-world evidence of BioMime sirolimus-eluting stent in obstructive coronary artery disease: the meriT-2 trial
AsiaIntervention 2024;10:186-194
Current status of percutaneous coronary interventions in diabetics with multivessel disease – is it time to challenge FREEDOM?
AsiaIntervention 2024;10:102-109
Angiographic patterns after drug-coated balloon angioplasty for de novo coronary lesions
AsiaIntervention 2024;10:119-125
Clinical prognostic value of a novel quantitative flow ratio from a single projection in patients with coronary bifurcation lesions treated with the provisional approach 
AsiaIntervention 2023;9:114-123
Safety and efficacy of a novel 3D-printed bioresorbable sirolimus-eluting scaffold in a porcine model
AsiaIntervention 2023;9:133-142
Carotid artery interventions – endarterectomy versus stenting
AsiaIntervention 2023;9:172-179